A patient on clozapine develops absolute neutrophil count (ANC) <500/mm3. Apart from stopping clozapine, which haematopoietic agent can be used to accelerate recovery of neutrophil count?
- A Erythropoietin (EPO)
- B Thrombopoietin receptor agonist (eltrombopag)
- C Granulocyte colony-stimulating factor (G-CSF, filgrastim) ✓
- D Granulocyte-monocyte colony-stimulating factor (GM-CSF, sargramostim) only if G-CSF unavailable
Explanation
Clozapine-induced agranulocytosis (ANC <500/mm3) is a life-threatening complication occurring in approximately 1% of patients. After stopping clozapine, G-CSF (filgrastim) stimulates proliferation and differentiation of neutrophil progenitors, accelerating ANC recovery. EPO acts on erythroid progenitors; eltrombopag is for thrombocytopenia; both G-CSF and GM-CSF can be used but G-CSF is first-line for pure neutrophil recovery.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.